Search Tag: AMOMED Pharma

ICU Management

Amomed-pharma-offers-drugs-for-severe-covid-19-cases

2020 23 Apr

AMOMED Pharma develops medicinal products for patients suffering from septic shock at the intensive care units. Septic shock is a life-threatening complication in COVID-19 patients.   Most COVID-19 admissions to the intensive care unit are due to severe lung disorders requiring invasive mechanical ventilation; many with acute respiratory distress...Read more

ICU Management

3-practical-tools-for-the-daily-work-in-the-icu-1

2020 23 Apr

We created the following three practical tools for physicians and medical personnel for their daily work in the ICU related to COVID-19 and sepsis.   Recommendations for Vasoactive Management for Hemodynamic Support in COVID-19 Patients with Septic Shock SOFA Score WHO Categorization of Clinical Syndromes Associated with COVID-19 in Adults  ...Read more

ICU Management

New-onset-of-atrial-fibrillation-in-the-icu-a-special-challenge-for-heart-failure-patients-1

2020 23 Apr

Atrial fibrillation (AF) is the most common heartbeat irregularity and associated with development of stroke, myocardial infarction and heart failure. Vice versa, the structural and neurohormonal changes in heart failure (HF), when the contractility of the heart muscle is reduced, make the development and progression of AF much more likely.  HF itself...Read more